IGM Biosciences Inc (IGMS) — Capital Reinvestment Ratio

Latest as of June 2022: 0.02x

IGM Biosciences Inc (IGMS) has a Capital Reinvestment Ratio of 0.02x as of June 2022, meaning it reinvests 0% of its operating cash flow ($111.29 Million) in capital expenditures ($1.82 Million). See IGMS net asset quality score to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.02x

Capex / Operating Cash Flow

Operating Cash Flow

$111.29 Million

USD

Capital Expenditures

$1.82 Million

USD

Data as of

Jun 2022

Most recent filing

Annual Capital Reinvestment Ratio for IGM Biosciences Inc (None–None)

Year-by-year Capital Reinvestment Ratio for IGM Biosciences Inc from None to None. For live market cap and broader valuation context, see IGM Biosciences Inc market capitalisation.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow